The assistant said in embarrassment: “Mr., I don’t know about this. The other party hung up the phone without letting me ask carefully…”

“What a bastard!” Jiro Kobayashi said with a black face, “If this is the case, then I can only think of a solution on this Oracle Pharmaceutical. In any case, I have to buy their formula patent!”

The assistant asked carefully: “Mr. Kobayashi, is this medicine effective?”

“Very good…” Jiro Kobayashi said gloomily, “At least ten times the effect of Kobayashi’s Niranex!”

The assistant seemed to be struck by lightning: “Ten times?! The difference is so big?!”

not tell this story. If we can get the prescription for Nova Dias, we can reverse everything and even take it to the next level. But if we

Kobayashi, such a good prescription is a cash

gritted his teeth and said: “It’s about the life and death of our Kobayashi Pharmaceutical Co., Ltd.! Regardless of whether they agree or not, I will force the

realize that he had completely fallen into the same madness as his

coveted the magical medicine that Charlie gave to Dr. Simmons, and wanted to use the magical medicine to cure the paralysis of his father,

Kobayashi, unknowingly, opened the door to the same fate as his

the results of

that this company was called Weaver Pharmaceutical. When we evaluated Chinese pharmaceutical companies before, we also evaluated this company. The overall market value at that time At around two to three billion

“Then it’s so good, why should it be renamed

changed to Oracle Pharmaceutical, their shareholding structure has also changed. Before the Weaver family held 100% of the shares, but after the change, the Weaver family only held 20% of the

Kobayashi asked in surprise: “Can’t you find out who

the key information of major shareholders. It is impossible to find out who owns the 80% of the shares, the president, I think This matter is not simple. The major shareholder behind this might have a strong background!

The Novel will be updated daily. Come back and continue reading tomorrow, everyone!

Comments ()

0/255